APA

Nganou-Makamdop K., Billingsley J. M., Yaffe Z., O'Connor G., Tharp G. K., Ransier A., Laboune F., Matus-Nicodemos R., Lerner A., Gharu L., Robertson J. M., Ford M. L., Schlapschy M., Kuhn N., Lensch A., Lifson J., Nason M., Skerra A., Schreiber G., Bosinger S. E. & Douek D. C. (20190122). Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. : PLoS pathogens.

Chicago

Nganou-Makamdop Krystelle, Billingsley James M, Yaffe Zachary, O'Connor Gregory, Tharp Gregory K, Ransier Amy, Laboune Farida, Matus-Nicodemos Rodrigo, Lerner Andrea, Gharu Lavina, Robertson Jennifer M, Ford Mandy L, Schlapschy Martin, Kuhn Nadine, Lensch Alexandra, Lifson Jeffrey, Nason Martha, Skerra Arne, Schreiber Gideon, Bosinger Steven E and Douek Daniel C. 20190122. Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. : PLoS pathogens.

Harvard

Nganou-Makamdop K., Billingsley J. M., Yaffe Z., O'Connor G., Tharp G. K., Ransier A., Laboune F., Matus-Nicodemos R., Lerner A., Gharu L., Robertson J. M., Ford M. L., Schlapschy M., Kuhn N., Lensch A., Lifson J., Nason M., Skerra A., Schreiber G., Bosinger S. E. and Douek D. C. (20190122). Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. : PLoS pathogens.

MLA

Nganou-Makamdop Krystelle, Billingsley James M, Yaffe Zachary, O'Connor Gregory, Tharp Gregory K, Ransier Amy, Laboune Farida, Matus-Nicodemos Rodrigo, Lerner Andrea, Gharu Lavina, Robertson Jennifer M, Ford Mandy L, Schlapschy Martin, Kuhn Nadine, Lensch Alexandra, Lifson Jeffrey, Nason Martha, Skerra Arne, Schreiber Gideon, Bosinger Steven E and Douek Daniel C. Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. : PLoS pathogens. 20190122.